Lv11
70 积分 2023-08-02 加入
Diagnosis and Management of Resistant Hypertension: A Review
8小时前
已完结
Sustained innovation in ATTR-CM - Twenty years of innovation in transthyretin amyloidosis
7天前
已完结
Lipoprotein(a) Reduction with Inclisiran, Alirocumab, Evolocumab, Enlicitide and Lerodalcibep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
17天前
已完结
Anti-remodeling therapies in pulmonary arterial hypertension
1个月前
已完结
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial
1个月前
已完结
Lepodisiran: An Updated Review on a Novel and Emerging Lipoprotein (a) Lowering Agent
2个月前
已关闭
Metrnl as a predictive biomarker for postprandial hypertriglyceridemia in overweight and obese populations
2个月前
已完结
Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis
2个月前
已完结
Guidelines in Action: Blood Pressure Management in the Setting of an Acute Intracerebral Hemorrhage
2个月前
已完结
Emerging insights into MicroRNA therapeutics and diagnostics for atherosclerotic cardiovascular disease: A narrative review
3个月前
已关闭
皖公网安备34019202002308
